Elucidating the exact pharmacological mechanism of action (MOA) of naturally developing compounds is usually hard. Whilst Tarselli et al. (60) made the primary de novo synthetic pathway to conolidine and showcased this Normally occurring compound efficiently suppresses responses to both chemically induced and inflammation-derived pain, the pharmaco… Read More